Seres Therapeutics, Inc. rose 5.40% in after-hours trading, with the company announcing its participation in the H.C. Wainwright Global Investment Conference in New York City. The company will present a company overview at 3:00 p.m. ET on September 8, 2025, which is expected to provide investors with valuable insights into the company's progress and future plans.
Comments
No comments yet